DeepMed Research

Tianjin Medical University Cancer Institute & Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer

Phase 2

Conditions: Gastric Cancer

Interventions: Drug: Toripalimab
Drug: Docetaxel
Drug: Fluorouracil
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2020-04-21

Last Posted Date: 2021-02-18

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 35

Registration Number: NCT04354662

Locations: 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China

PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC

Phase 2

Conditions: Hepatocellular Carcinoma Non-resectable

Interventions: Combination Product: PD-1 mAb combined with TACE and lenvatinib

First Posted Date: 2020-02-17

Last Posted Date: 2020-02-17

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 56

Registration Number: NCT04273100

Locations: 🇨🇳
Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer

Phase 2

Active, not recruiting

Conditions: Gastric Cancer Stage IV

Interventions: Drug: sintilimab
Drug: apatinib
Drug: S1
Drug: Nab paclitaxel

First Posted Date: 2020-02-13

Last Posted Date: 2023-07-06

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 47

Registration Number: NCT04267549

Locations: 🇨🇳
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.

Not Applicable

Conditions: Implant Breast Reconstruction
Bovine Pericardial Patch
TiLOOP® Bra Mesh

Interventions: Procedure: TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction
Procedure: Bovine Pericardial Patch in Immediate Implant Breast Reconstruction

First Posted Date: 2020-01-29

Last Posted Date: 2020-02-05

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 176

Registration Number: NCT04245930

Locations: 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Clinical Application of Nutrition Support Package Before Hepatectomy

Not Applicable

Conditions: Hepatectomy
Liver Neoplasms
Nutrition Therapy

Interventions: Dietary Supplement: 300 calories or 500 calories nutrient rich in branched chain amino acids and dietary fiber
Behavioral: Dietary mission

First Posted Date: 2020-01-06

Last Posted Date: 2020-01-06

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 200

Registration Number: NCT04218253

Locations: 🇨🇳
Tianjin Medical University cancer Instituteand Hospital, Tianjin, China

To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy

Completed

Conditions: Esophageal Squamous Cell Carcinoma
Chemoradiotherapy
Enteral Nutrition

Interventions: Dietary Supplement: Dietary guidance

First Posted Date: 2019-12-16

Last Posted Date: 2023-02-16

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 156

Registration Number: NCT04199832

Locations: 🇨🇳
Department of Radiation Oncology, Tianjin Medical University cancer Institute and Hospital, Tianjin, Tianjin, China

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Phase 1

Conditions: Second-line Treatment
Non-small Cell Lung Cancer

Interventions: Biological: CTL
Biological: Toripalimab

First Posted Date: 2019-12-10

Last Posted Date: 2020-07-07

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 10

Registration Number: NCT04193098

Locations: 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Not Applicable

Conditions: Small Cell Lung Cancer

Interventions: Drug: Mecapegfilgrastim

First Posted Date: 2019-11-21

Last Posted Date: 2019-11-21

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 93

Registration Number: NCT04171986

Locations: 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO

Phase 2

Conditions: Unresectable Esophageal Cancer

Interventions: Radiation: Definitive Radiochemotherapy
Procedure: Neoadjuvant Radiochemotherapy followed by surgery

First Posted Date: 2019-10-24

Last Posted Date: 2019-11-01

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 60

Registration Number: NCT04137679

Locations: 🇨🇳
Department of Radiation Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer

Phase 2

Conditions: Small Cell Lung Cancer

Interventions: Drug: Apatinib S-1

First Posted Date: 2019-10-16

Last Posted Date: 2019-10-16

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 20

Registration Number: NCT04128800

Locations: 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy